| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Skerlj Renato is a Chief Scientific Officer at X4 Pharmaceuticals, Inc. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $173K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2020 | XFOR X4 Pharmaceuticals, Inc | Chief Scientific Officer | Sell | 5,834 | $8.05 | $46,963.70 | -12.2% |